SEC Form 4 · accession 0001140361-16-055418
MACROGENICS INC · MGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jon Marc Wigginton
Officer — Sr VP, Clinical Dev & CMO
Period of report
Feb 25, 2016
Accepted (ET)
Feb 29, 2016 · 12:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001125345
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 25, 2016 | A | 30,000 | $0.00 | A | 30,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Consists of restricted stock units granted under the MacroGenics 2013 Equity Incentive Plan.
- F2These restricted stock units will vest on February 25, 2018, subject to continued employment with the Company, or earlier upon termination, other than for cause. Upon vesting, each restricted stock award will convert into one share of common stock of the Company